Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 4, 1999, Pages 1329-1333

  Borson Chazot, Françoise ^a   Serusclat, André ^a   Kalfallah, Yadh ^c   Ducottet, Xavier ^b   Sassolas, Geneviève ^c   Bernard, Sophie ^a   Labrousse, Florence ^a   Pastene, Jorge ^b   Sassolas, Agnes̀s ^c   Roux, Yves ^a   Berthezène, François ^a  

^a Hopital de l'Antiquaille   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c HÔPITAL NEUROLOGIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATREM;

ADULT; ARTERY INTIMA; ARTERY MEDIA; ARTERY WALL; ARTICLE; ATHEROGENESIS; BODY FAT; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THICKNESS; TREATMENT OUTCOME;

EID: 0033349835     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.4.1329     Document Type: Article

References (30)

1. Premature mortality due to cardiovascular disease in hypopitultarism
2. Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: Need for additional growth hormone substitution?
3. Increased cerebrovascular mortality in patients with hypopituitarism
4. Ultrasonographyically assessed carotid morphology and the risk of coronary heart disease
5. Ultrasound B-mode imaging in observational studies of atherosclerotic progression
6. Risk factors for early carotid atherosclerosis in middle-aged French women
7. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom free hypopituitary adults
8. Increased arterial intima-media thickness in childhood onset growth hormone deficiency
9. Fasting and postprandial lipid abnormalities in hypopitultary women receiving conventional replacement therapy
10. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency
11. Effects of 1 year growth hormone therapy on serum lipoprotein levels in growth hormone- deficient adults
12. The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults
13. A specific radioimmunoassay for IGF I: The interference of IGF binding proteins can be blocked by excess IGF I
14. An updated coronary risk profile. A statement for health professionals
15. 2 max
16. Use of monitoring software to improve the measurement of carotid wall thickness by B-mode imaging
17. Minimally oxydized LDL as estimated by a new method increase in plasma of type 2 diabetic patients with atherosclerosis or nephropathy
18. GH therapy reverses early atherosclerotic changes in GH-deficient hypopituitary adults
19. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events
20. A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries
21. Pravastatin, lipids, and atherosclerosis in the carotid arteries (Plac II)
22. The effect of cholesterol reduction with fluvastatin on aortic compliance, coronary calcification and carotid intimal-medial thickness: A pilot study
23. A dose response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults
24. Increased common carotid intima-media thickness. Adaptative response or a reflection of atherosclerosis? Findings from the Rotterdam study
25. Cardiovascular and renal effects of growth hormone
26. Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults
27. Endothelial-dependent vascular effects of insulin and insulin-like growth factor I in the perfused rat mesenteric artery and aortic ring
28. Direct demonstration of insulin-like-growth factor I induced nitric oxyde production by endothelial cells
29. Nitric oxide mediates the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency
30. Serum total IGF 1, free IGF 1, and IGFBP-1 levels in an elderly population. Relation to cardiovascular risk factors and disease